Home page > News
 
 
Chiesi Group 2023 Financial Results
Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices Highlights from Chiesi...
1/11
ARCHIVE NEWS
Important recognitions for Chiesi Group from the Carbon Disclosure Project (CDP) and Cerved Rating Agency
RARE IS NOT SO RARE: #WEWEARSTRIPES CAMPAIGN 2022 LAUNCHED TO MARK RARE DISEASE DAY
Chiesi accelerates path toward full sustainability despite Covid-19 pandemic
Chiesi continues cultural transformation with new visual identity that mirrors patients’ language and experiences
Chiesi Group: performance is up in 2020
Chiesi Global Rare Diseases Recognizes Rare Disease Day Highlighting Importance of Staying Connected for Information and Support
Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH).
Chiesi Group increases support measures and announces new funds for employees, patients and healthcare providers in response to COVID-19 pandemic